Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis

Emerging Infectious Diseases

Volumn 19, Issue 8, 2013, Pages 1245-1252

  Tate, Jacqueline E ^a   Mijatovic Rustempasic, Slavica ^a   Tam, Ka Ian ^a   Lyde, Freda C ^a   Payne, Daniel C ^a   Szilagyi, Peter ^b   Edwards, Kathryn ^c   Staat, Mary Allen ^d   Weinberg, Geoffrey A ^b   Hall, Caroline B ^b   Chappell, James ^c   McNeal, Monica ^d   Gentsch, Jon R ^a   Bowen, Michael D ^a   Parashar, Umesh D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; ENZYME IMMUNOASSAY; GASTROENTERITIS; HUMAN; IMMUNIZATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; VIRUS DETECTION;

ACUTE GASTROENTERITIS; CHILDREN; DIAGNOSIS; ENZYME IMMUNOASSAY; ROTAVIRUS; RT-PCR; VIRUSES;

ACUTE DISEASE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROENTERITIS; HUMANS; INFANT; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINE POTENCY;

EID: 84880711963     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1908.130461     Document Type: Article

References (24)

1. Nordgren J, Bucardo F, Svensson L, Lindgren PE. Novel light-uponextension real-time PCR assay for simultaneous detection, quantification, and genogrouping of group A rotavirus. J Clin Microbiol. 2010;48:1859-1865. http://dx.doi.org/10.1128/JCM.02288-09
2. Jothikumar N, Kang G, Hill VR. Broadly reactive TaqMan assay for real-time RT-PCR detection of rotavirus in clinical and environmental samples. J Virol Methods. 2009;155:126-131. http://dx.doi. org/10.1016/j.jviromet.2008.09.025
3. Freeman MM, Kerin T, Hull J, McCaustland K, Gentsch J. Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay. J Med Virol. 2008;80:1489-1496. http://dx.doi.org/10.1002/jmv.21228
4. Stockman LJ, Staat MA, Holloway M, Bernstein DI, Kerin T, Hull J, et al. Optimum diagnostic assay and clinical specimen for routine rotavirus surveillance. J Clin Microbiol. 2008;46:1842-1843. http://dx.doi.org/10.1128/JCM.02329-07
5. Gunson RN, Miller J, Leonard A, Carman WF. Importance of PCR in the diagnosis and understanding of rotavirus illness in the community. Commun Dis Public Health. 2003;6:63-65.
6. Amar CF, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin J. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case- control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis. 2007;26:311-323. http://dx.doi.org/10.1007/ s10096-007-0290-8
7. Phillips G, Lopman B, Tam CC, Iturriza-Gomara M, Brown D, Gray J. Diagnosing rotavirus A associated IID: using ELISA to identify a cut-off for real time RT-PCR. J Clin Virol. 2009;44:242-245. http://dx.doi.org/10.1016/j.jcv.2008.12.001
8. Kang G, Iturriza-Gomara M, Wheeler JG, Crystal P, Monica B, Ramani S, et al. Quantitation of group A rotavirus by real-time reverse-transcription-polymerase chain reaction: correlation with clinical severity in children in South India. J Med Virol. 2004;73:118-122. http://dx.doi.org/10.1002/jmv.20053
9. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33. http://dx.doi.org/10.1056/NEJMoa052664
10. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22. http://dx.doi.org/10.1056/NEJMoa052434
11. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199-e207. http://dx.doi.org/10.1542/peds.2009-1021
12. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, et al. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010;29:1133-1135. http://dx.doi.org/10.1097/INF.0b013e3181ed18ab
13. Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011;128:e1474-e1481. http://dx.doi.org/10.1542/peds.2011-1006
14. Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics. 2011;128:e267-e275. http://dx.doi. org/10.1542/peds.2010-3722
15. Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. Clin Infect Dis. 2011;52:191-199. http://dx.doi.org/10.1093/cid/ciq101
16. Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil. J Infect Dis. 2010;201:363-369. http://dx.doi.org/10.1086/649843
17. Castilla J, Beristain X, Martinez-Artola V, Navascues A, Garcia Cenoz M, Alvarez N, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine. 2012;30:539-543. http://dx.doi.org/10.1016/j.vaccine.2011.11.071
18. Martinón-Torres F, Bouzón Alejandro M, Redondo Collazo L, Sánchez Lastres JM, Pértega Díaz S, Seoane Pillado MT, et al. Effectiveness of rotavirus vaccination in Spain. Hum Vaccin. 2011;7:757-761. http://dx.doi.org/10.4161/hv.7.7.15576
19. Muhsen K, Shulman L, Kasem E, Rubinstein U, Shachter J, Kremer A, et al. Effectiveness of rotavirus vaccines for prevention of rotavirus gastroenteritis-associated hospitalizations in Israel: a case- control study. Hum Vaccin. 2010;6:450-454. http://dx.doi.org/10.4161/ hv.6.6.11759
20. Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics. 2008;122:1235-1243. http://dx.doi.org/10.1542/peds.2007-3378
21. Payne DC, Edwards KM, Bowen MD, Keckley E, Peters J, Esona MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics. 2010;125:e438-e441. http://dx.doi.org/10.1542/peds.2009-1901
22. Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009. Clin Infect Dis. 2011;53:245-253. http://dx.doi. org/10.1093/cid/cir307
23. Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009;124:465-471. http://dx.doi.org/10.1542/peds.2008-3528
24. Tate JE, Mutuc JD, Panozzo CA, Payne DC, Cortese MM, Cortes JE, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J. 2011;30(Suppl):S30-S44. http://dx.doi.org/10.1097/INF.0b013e3181ffe3eb